Profusa, Inc. (PFSA) Stock Profile — Insider Trades & Financials

Net Income-$17.9M

EPS$-2.29

Market Cap$80.8M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Ben Hwang

CEO & Executive Director

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Founded: 2009
Employees: 15
Headquarters: Berkeley, California, United States
Website

⚡

Core Efficiency

ROE?

52.82%

ROA?

-422.10%

D/E Ratio?

-1.13

📊

Profitability Ratios

Current Ratio?

0.18

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Mar 14, 2026 (26 days ago)

Quarterly Report (10-Q) — Based on filing pattern

Mar 14, 2026

Predicted10-Q

Nov 19, 2025

10-QQ3 20251d after period end

Aug 14, 2025

10-QQ2 20252d after period end

Jun 13, 2025

10-QQ1 20250d after period end

Mar 31, 2025

10-KQ4 20243d after period end

Mar 31, 2025

10-KFY 202490d after period end

Dec 17, 2024

10-QQ3 20240d after period end

Nov 15, 2024

10-QQ2 20241d after period end

Oct 9, 2024

10-QQ1 20240d after period end

Loading company sections...

Profusa, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness